Program to date

Buffet Dinner
The residence of H.E. U.S. Ambassador Michael M. Wood
Welcoming remarks by Ms Barbro C. Ehnbom, Chairman SALSS

Registration

Setting the stage: Moderator, Udayan Gupta,
WSJ Journalist and Author
View biografy about Udayan Gupta

Introductory remarks: To be announced

Keynote address: Dr. William Haseltine,
Chairman, Haseltine Global Health
Founder, Human Genome Science

Break

Panel: Commercialization – From research to business
Moderator: Udayan Gupta
Introduction by Professor Mathias Uhlén

Panel:
Perspective- Institute of higher learning
Harriet Wallberg-Henriksson, VD Karolinska Institutet

The Accelerated growth perspective
Dr. Yuval Binur, General Partner, Oxford BioScience

From Bench to Profit
Cynthia Ekberg Tsai, Managing Director,
Madelin Fund, MD Anderson

The Investors Perspective
Mikael Brönnegård, Director, HealthCare, InnKap

Break

The Swedish landscape – Company presentations
Medivir, Neuronova, Swedish Orphan

Future outlook – what lies ahead

Lunch
Welcome: Charlotte Erkhammar, CEO, Kreab Group
Lunch speaker: Tony Svensson, Director ISA, New York

Global Investment Trends 2006

A Swedish success story
Laurent Leksell, Founder and Director, Elekta

Break

Panel: Internationalization – Success Stories
Moderator: Udayan Gupta

Panel:
Biacore GE Strategy
Peter von Ehrenheim, CEO, GE Healthcare Life Science

International Venture Capital Perspective
William Gedale, Managing Partner, NGN BioMed, L.P.

The I.P. Perspective
Dimitrios Drivas, White & Case

Analyst's Perspective, the LifeScience Market in Scandinavia
Benjamin Nordin, Head Analyst, Kaupthing bank

Reverse Merging
Dr. Robin L. Smith, Chairman, Neocell

Equity into Early Stage
Jay Lobell, President, Paramount BioCapital

Concluding remarks by moderator

Dinner Cruise around Stockholm

Coffee reception

Keynote speaker:
Professor Hans Wigzell, Scientific Advisor to the Swedish Government

The Swedish landscape – Company presentations
ActiveBiotech, LinkMed, Biolipox

Focus: This years topic - Life Science and the Developing World, from Bird Flu and the vaccines to the market potential in India and China
Moderator: Udayan Gupta

Panel:
Swedish Venture Capital Perspective
Magnus Persson, HealthCap

Big corporate perspective
Niklas Prager, President of Pfizer in Sweden

Global overview
Head of Ernst & Young. Life Science Practice

From antiterrorism to cancer
Dr. Yakov Kogan, Chairman Cleveland BioLabs

Antiviral treatments of emerging pandemics
Dr. Johnson Lau, Managing Partner, Roth Capital

The Indian Connection
Parag Saxena, Vedanta Capital

Company presentations
In separate presentation rooms: Bionovo (U.S.), NeoCell (U.S)

Final Remarks - Moderator

Lunch at Grand Hotel
Hosted by Robert Charpentier, VD, Kaupthing Bank